医学分子生物学杂志 ›› 2025, Vol. 22 ›› Issue (4): 346-353.doi: 10.3870/j.issn.1672-8009.2025.04.007

• 论著 • 上一篇    下一篇

miR-181c 通过靶向 MICU1 调控肺移植小鼠心肺功能康复 #br#

  

  1. 新疆维吾尔自治区人民医院1康复科,2神经内科 乌鲁木齐市, 830001
  • 出版日期:2025-07-31 发布日期:2025-07-18
  • 基金资助:
    新疆维吾尔自治区自然科学基金 (No. 2024D01C72)

Effect of miR-181c on Cardiopulmonary Function Rehabilitation in Mice Undergoing Lung Transplantation by Targeting MICU1 #br#

  1. 1Department of Rehabilitation,2 Department of Neurology, Xinjiang Uygur Autonomous Region Peoples Hospital, Urumqi, 830001, China
  • Online:2025-07-31 Published:2025-07-18

摘要: 目的 探讨微小 RNA ( miRNA) -181c 通过线粒体钙单向转运蛋白 1 ( mitochondrial calciumuniporter 1, MICU1) 对肺移植小鼠心肺功能恢复的作用及机制方法 54 C57BL / 6 小鼠分为正常组肺移植组、 inhibitor-NC 肺移植 + miR-181c-inhibitor 肺移植 + miR-181c-inhibitor + si-NC 组和肺移植 + miR-181c-inhibitor + si-MICU1 , 每组 n = 9。 正常组仅开胸麻醉; 其余均行自体左肺原位移植, 术后每周静脉注射 0. 2 mL 生理盐水或 10 nmol / mL 抑制剂/ siRNA, 持续 60 d。 qRT-PCR 和蛋白质印迹检测 miR-181cMICU1 表达, 双荧光素酶报告实验验证 miR-181c MICU1 的靶向关系; HE 染色评估肺组织病理; 小动物肺功能仪检测 0. 15 s 用力呼气容积占用力肺活量百分比 (FEV0. 15 / FVC)、 呼气峰流速值 (PEF)、 最大通气量 (MVV)、 一氧化碳弥散量 (DLCO)、 残气量 (RV); 超声心动图检测左心室射血分数 ( LVEF)、 左心室缩短分数 (LVFS)、 左心室舒张末期内径 (LVEDD)、 左心室收缩末期内径 ( LVESD)、 左心室舒张末期容积 (LVEDV)、 左心室收缩末期容积 (LVESV)。 结果 与正常组相比, 肺移植组 miR-181c 上调 (P< 0. 05), MICU1 下调 (P< 0. 05), 二者负相关 ( r = - 0. 378, P = 4. 21 × 10 - 4 )。 报告基因实验显示 miR- 181c 能特异性抑制 MICU1 3′UTR-WT 荧光活性 (P< 0. 05)。 敲低 miR-181c MICU1 表达水平恢复, 肺组织病变减轻, FEV0. 15 / FVC、 PEF、 MVV、 DLCO LVEF、 LVFS 增加, RV、 LVESD、 LVEDV、 LVESV 减少(P< 0. 05); 联合敲低 miR-181c si-MICU1 致上述改善消失 (P< 0. 05)。 结论 miR-181c 通过靶向抑制MICU1 显著影响肺移植后小鼠心肺功能; 敲低 miR-181c 有助于改善术后心肺功能

关键词: 微小 RNA-181c, 线粒体钙单向转运蛋白 1, 肺移植, 心肺功能康复

Abstract: Objective To investigate how miR-181c influences cardiopulmonary recovery afterlung transplantation in mice by targeting mitochondrial calcium uniporter 1 (MICU1) . Methods Fifty-four adult male C57BL / 6 mice were randomly assigned to six groups (n = 9 each): Normalgroup, Lung Transplantation group, Lung Transplantation + inhibitor-NC group, Lung Transplantation + miR-181c-inhibitor group, Lung Transplantation + miR-181c-inhibitor + si-NC group, andLung Transplantation + miR-181c-inhibitor + si-MICU1 group. The Normal group underwent anesthesia and thoracotomy only; the other groups received autologous left lung orthotopic transplantation,followed by weekly tail-vein injections (0. 2 mL) of saline or 10 nmol / mL inhibitor / siRNA for 60days. qRT-PCR and Western blotting were use to detect miR-181c and MICU1 mRNA and protein expression levels. Dual-luciferase gene reporter assay was performed to verify the targeting relationship between miR-181c and MICU1. Pulmonary pathology was assessed by hematoxylin-eosin (HE) staining. Pulmonary function was assessed using a small animal pulmonary function test system [0. 15 s forced expiratory volume as a percentage of forced vital capacity ( FEV0. 15 / FVC), peak expiratory flow (PEF), maximum ventilation volume ( MVV), diffusing capacity of the lung for carbon monoxide ( DLCO), and residual volume ( RV)] . Cardiac function was detected using small animal ultrasound imaging technology [ left ventricular ejection fraction ( LVEF), left ventricular fractional shortening (LVFS), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter ( LVESD), left ventricular end-diastolic volume ( LVEDV), and left ventricular end-systolic volume (LVESV)] . Results The expression level of miR-181c was elevated and that of MICU1 was reduced in the Lung transplantation group versus those in the Normalgroup (P< 0. 05), with a significant negative correlation (r = - 0. 378, P = 4. 21 × 10 - 4 ) . miR- 181c mimic suppressed MICU1-3′ UTR-WT luciferase activity ( P < 0. 05 ) but not 3′ UTRMUT. Inhibition of miR-181c expression restored MICU1 expression, and reduced lung lesions, and improved FEV0. 15 / FVC, PEF, MVV, DLCO, LVEF, LVFS, and decreased RV, LVESD, LVEDV, LVESV ( all P < 0. 05) . These gains were abolished by co-silencing MICU1 and miR-181c (P< 0. 05) . Conclusion miR-181c impairs cardiopulmonary recovery after lung transplantation bytargeting MICU1. miR-181c inhibition enhances post-transplant function.

Key words:

microRNA-181c, mitochondrial calcium uniporter 1, lung transplantation, cardiopulmonary function recovery


中图分类号: